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Abstract
Background: MicroRNAs are a class of small regulatory RNAs that modulate a variety of biological processes, including
cellular differentiation, apoptosis, metabolism and proliferation. This study aims to explore the effect of miR-34a in
hepatocyte proliferation and its potential role in liver regeneration termination.
Methodology/Principal Finding: MiR-34a was highly induced after partial hepatectomy. Overexpression of miR-34a in BRL-
3A cells could significantly inhibit cell proliferation and down-regulate the expression of inhibin bB (INHBB) and Met. In BRL-
3A cells, INHBB was identified as a direct target of miR-34a by luciferase reporter assay. More importantly, INHBB siRNA
significantly repressed cell proliferation. A decrease of INHBB and Met was detected in regenerating liver.
Conclusion/Significance: MiR-34a expression was upregulated during the late phase of liver regeneration. MiR-34a-
mediated regulation of INHBB and Met may collectively contribute to the suppression of hepatocyte proliferation.
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Introduction
The liver has a remarkable capacity to regenerate itself in
response to signals as physical, chemical, nutritional, vascular, or
virus-induced liver injury [1]. Partial hepatectomy (PHx) is widely
used as a liver regeneration (LR) model in scientific research since
it is free of side effects associated with toxic regenerative stimuli
[2]. LR after PHx can be divided into three distinct phases: an
initiation step, a proliferation step and a termination step [3–5]. In
the termination stage, the newly divided cells may exit from the
cell cycle under the regulation of some ‘stop’ signals, and return to
the G0 quiescent state [6]. However, these ‘stop’ signals leading to
cell proliferation inhibition are still poorly defined.
Transforming growth factor-b is the most well-recognized
candidate for the ‘stop’ signal [7,8], because it is highly expressed
in the late phase of liver regeneration and can strongly inhibit
hepatocyte proliferation in vitro and in vivo. Another potential
candidate is activin, which belongs to the TGF-b superfamily.
Activin A, a homodimer of two b A subunits encoded by the inhibin
bA( INHBA) gene, is an autocrine inhibitor of hepatocyte DNA
synthesis and is strongly increased at 3–5 d after PHx [9,10]. When
the action of activin A is neutralized by administration of follistatin,
an activin antagonist, liver regeneration after partial hepatectomy is
accelerated [11,12]. Activin B, a homodimer of two bB subunits
encoded by the inhibin bB( INHBB) gene, is related to activin A.
However, it still remains unknown whether activin B has any roles
in hepatocyte proliferation. Moreover, a recent study have shown
that integrin-linked kinase (ILK) may also play an important role in
controlling the termination of LR, partly through HGF/Met, b-
catenin and Hippo kinase pathways [13]. Thus, as potential
regulators in the termination stage of LR, the specific roles and
mechanisms of these factors remain to be elucidated.
MicroRNAs (miRNAs) are a class of small regulatory RNAs that
modulate a variety of biological processes, including cellular
differentiation, apoptosis, metabolism and proliferation, by
targeting different genes [14]. Recently, some studies have
described the roles of miRNAs in the process of LR. For instance,
miR-21 expression was up-regulated during the early phases of
LR, which inhibits Peli1 and potentially regulate NF-kB signaling
[15]; miR-23b was down-regulated in the termination phase of
LR, and may contribute to activation of the TGF-b1/Smad3
signaling [16]. Thus, analysis about microRNA and related target
genes may provide unique insights into the ‘stop’ signal of LR and
hepatocyte proliferation.
In the present study, we mainly focused on miR-34a based on its
expression pattern after PHx and its antiproliferative function in
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20238rat hepatocytes, along with its target genes. Our data suggests that
miR-34a might also be a potential ‘stop’ signal that contributes to
the suppression of hepatocyte proliferation during the late phase of
LR.
Results
MiR-34a is induced in response to PHx
To illustrate the miRNA expression pattern in the termination
phase of LR, we performed a comprehensive miRNA expression
profiling analysis on 6 rats 5 d after PHx or SH. As shown in
Figure 1A, we identified 8 up-regulated and 2 down-regulated
miRNAs, in which miR-34a had at least 5-fold difference in
expression between PHx and SH, with a P value ,0.01. We then
studied how miR-34a expression changes during LR on different
time points. As revealed by qRT-PCR analysis, the regeneration of
the remnant livers after PHx caused a transient increase in miR-
34a expression with ,2-fold and ,6-fold at 3 and 5 d when
compared with SH control on each time point (Figure 1B).
MiR-34a inhibits BRL-3A cell proliferation
To evaluate the effect of miR-34a in regulating rat liver cell
proliferation, a MTT cell proliferation assay and a cell cycle
analysis were used (described in ‘‘Materials and methods’’). Briefly,
BRL-3A immortalized rat liver cells were transfected with miR-
34a or NC. MTT assay was performed at 2-day intervals, while
cell cycle analysis was conducted 48 h after infection. As shown in
Figure 2A, miR-34a markedly reduced BRL-3A cell growth at 4 d
and more remarkably at 6 d (P,0.01). The growth inhibitory
effect of miR-34a can also be sustained by the data of cell cycle
analysis, in which the percentages of G2 phase cells in miR-34a
and NC groups were (23.1464.26)% and (8.4862.93)% respec-
tively, indicating a subpopulation of cells arrested in G2 phase by
miR-34a (Figure 2B,C).
MiR-34a down-regulates INHBB and Met expression
Although the precise mechanisms of the termination of LR
remain elusive, some important pathways have been linked to this
process, such as, TGF-b, activin A, and ILK pathways [7–9,13].
Therefore, we presumed that miR-34a may possess some target
genes associated with these pathways. Bioinformatic tools for
putative miR-34a target genes (Targetscan, http://www.targets-
can.org/) and pathway classification analysis of these candidate
target genes (Molecular Annotation System, MAS, http://bioinfo.
capitalbio.com/mas) were used (Tables S1, S2).
INHBB, which encodes a subunit of activin AB and activin B,
was identified by bioinformatic analysis. Although Met has been
proved to be a target of miR-34a in HeLa cells and HepG2 cells
[17,18], it is still involved in validation in BRL-3A cells. qRT-PCR
and westernblot analysis revealed that miR-34a drastically
inhibited the expression of INHBB and Met on both mRNA
and protein levels (Figure 3A,B). To detect whether the regulation
of INHBB was direct, we fused the 39-UTR region of INHBB to a
luciferase system. As shown in Figure 3C,D, miR-34a remarkably
repressed the expression of luciferase containing an original miR-
34a binding site (INHBB-UTR) but not a mutant binding site
(INHBB-Mu-UTR). And mutations in seed complementary sites of
the 39-UTR region of INHBB could restore the luciferase
expression.
INHBB downregulation represses hepatocyte
proliferation
In the present study, Met and INHBB were confirmed as the
target gene of miR-34a. Met is known to play a critical role in the
progressing and termination stage of liver regeneration [13].
However, the function of INHBB in hepatocyte proliferation still
needs to be clarified. In order to prove that INHBB functions as a
promoter in proliferation like Met, we then studied the effect of
INHBB siRNA on hepatocyte proliferation. Cells were transfected
with INHBB siRNA, Control siRNA or FAM-siRNA Control.
The FAM-siRNA Control enables visualization of transfection
efficiency 4–6 hours post transfection via bright (Figure 4A, left)
and fluorescence (Figure 4A, right) microscope. The knockdown
efficiency of INHBB was verified by real-time PCR (Figure 4B). In
MTT cell proliferation assay, cells treated with INHBB siRNA or
Control siRNA sequences were re-seeded in 96-well plates 48 h
post transfection (described in ‘‘Materials and methods’’) and were
allowed to grow for indicated times. As revealed in Figure 4C,
INHBB siRNA strongly repressed BRL-3A cell proliferation
(P,0.05).
Expression of miR-34a candidate target genes in
regenerating liver tissues
To determine whether miR-34a potentially regulates the
expression of INHBB and Met during LR, we tested the
expression of INHBB and Met in regenerating liver tissues at
5 d after PHx, when miR-34a was highly induced. By qRT-PCR
and westernblot analysis, we observed intensive down-regulation
of INHBB and Met on both mRNA and protein levels in PHx rats,
Figure 1. Differentially expressed miRNAs during liver regen-
eration (LR). (A) miRNA expression profiling at 5 d after partial
hepatectomy (PHx). Each data point represents the ratio of miRNA
expression levels under PHx to Sham operation (SH). Ratio values .1.5
or ,0.7 were considered up-regulated (red) or down-regulated (green)
in PHx rats compared to SH rats. (B) The expression pattern of miR-34a
during LR by quantitative real-time PCR (qRT-PCR) analysis. miR-34a
levels were normalized to that of u6.*P,0.05, ** P,0.01, vs SH control
at each time point.
doi:10.1371/journal.pone.0020238.g001
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inversely expressed (Figure 5A,B). Moreover, we found that after
PHx INHBB mRNA had declined at 3 d, and was markedly
repressed at 5 d and 7 d; while INHBA mRNA had increased at
3 d, and then was strongly increased at 5 d and 7 d (Figure 5C).
Our data indicated that activin B (homodimer of two INHBB
proteins) had an opposite expression pattern as compared to
activin A (homodimer of two INHBA proteins) (Figure 5D).
Discussion
Despite strong evidence that miRNAs are involved in the
priming and progression phase of LR, little is known about how
miRNAs affect the termination stage. To gain more insights into
the roles of miRNAs, we performed a miRNA microarray analysis
on late-phase regenerating livers. MiR-34a with ,6-fold change
was identified by microarray and qRT-PCR (Figure 1). Intrigu-
ingly, miR-34a is well known for its anti-oncogenic activity in
several cancers, including hepatocellular carcinoma [17,19–21].
Therefore, we hypothesized that miR-34a was a key suppressor of
hepatocyte proliferation and might be a negative regulator during
LR, like other ‘stop’ signals as TGF-b and activins.
To confirm the role of miR-34a in normal hepatocytes, we used
cultured rat liver cells (BRL-3A cells) as cell models. Our data
showed that miR-34a drastically inhibited BRL-3A cell growth
and induced a significant G2/M arrest (Figure 2). However, in
previous study, ectopic miR-34a was shown to induce a cell cycle
arrest in the G1-phase, thereby suppressing tumor cell prolifera-
tion [18,22,23]. We assumed that the discrepancy may be caused
by the different backgrounds and molecular mechanisms between
normal cells and tumor cells. For instance, in tumor cells, the
aberrant activated E2F complexes can work on the target genes
whose products regulate the G1/S transition; and loss of
regulation at the G1/S transition appears to be a common event
among virtually all types of human tumor [24]. Moreover, our
data were also supported by a recent study of Factor, who
discovered that c-Met deficient hepatocytes were blocked in early/
mid G2 phase [25].
To determine how miR-34a influences the hepatocyte prolifer-
ation, we then used a Molecular Annotation System (MAS) to
categorize all putative target genes of miR-34a predicted by
Targetscan (Table S1). Interestingly, we identified INHBB as a
target gene of miR-34a in the activin pathway. In this study, we
show that miR-34a not only inhibits INHBB in a direct way
(Figure 3) but also may result in the down-regulation of INHBB in
regenerating liver (Figure 5). More importantly, we proved that
knockdown of INHBB via a siRNA system could strongly repress
rat hepatocyte proliferation (Figure 4). In activin family
(Figure 5D), activin A (homodimer of two INHBA proteins) has
been shown to decelerate hepatocyte growth in LR. Interestingly,
in our findings, activin B (homodimer of two INHBB proteins)
seemed to play an opposite role in cell proliferation with an
opposite mRNA expression pattern after PHx (Figure 5C). There
have been a few reports comparing the biological potency of
activin A and activin B. For example, stimulation of DNA
synthesis by EGF could be inhibited by activin A, but not by
activin B [26]. It has been reported that activin A and activin B
had opposite effects on Ca
2+ signaling in islet cells, with activin A
increasing, but activin B decreasing [27]. Therefore, it is
conceivable that the overall effect of activins during LR may
result from the balance between the expression of INHBB and
INHBA subunit genes.
Figure 2. MiR-34a induced growth inhibition in rat hepatocytes. (A) BRL-3A cells treated with miR-34a mimics (miR-34a) or negative control
(NC) were seeded in 96-well plates and examined at indicated time points. The absorbance of methylthiazoletetrazolium by each sample was
recorded at 570 nm after staining. (B,C) Cells treated with miR-34a or NC were analyzed by flow cytometry as described in ‘‘Materials and methods’’
for cell cycle distribution analysis.
doi:10.1371/journal.pone.0020238.g002
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miR-34a in the regenerating livers. It has been reported that an
increase in Met, together with its ligand HGF, could lead to
impaired liver regeneration [13]. In accordance with previous
study, our investigation suggests that miR-34a-mediated inhibition
of Met may also contribute to the suppression of hepatocyte
proliferation during LR.
In conclusion, miR-34a is strongly induced in the late phase of
LR after PHx. Elevated miR-34a greatly suppressed hepatocyte
proliferation by targeting INHBB and Met. Our data also
provided a tantalizing hint that miR-34a might be a ‘stop’ signal
in regenerating hepatocytes.
Materials and Methods
Ethics statement
All animals were cared appropriately according to the
Institutional Animal Care Instructions approved by the Animal
and Ethics Review Committee, Second Military Medical Univer-
sity, Shanghai, China. All experimental procedures were approved
by the Animal and Ethics Review Committee of the Second
Military Medical University (SCXK 2007-0003).
Animals and operative procedure
Male Sprague-Dawley rats (180–210 g) were maintained on a
normal diet with free access to water. After they were anesthetized
with sodium pentobarbital (50 mg/kg, intraperitoneally), 70%
partial hepatectomy (PHx) was performed as described by Higgins
and Anderson [28]. For sham operation (SH), rats underwent
abdominal surgery without liver resection. At indicated time
points: 1, 3, 5, 7 days (d) after surgery, animals were sacrificed and
the remnant liver tissues were collected.
Microarrays
Total RNA samples from SH and PHx rats (5 d after PHx) were
analyzed by CapitalBio Corporation (CapitalBio, Beijing, China)
Figure 3. Analyses of candidate target genes of miR-34a. (A) miR-34a decreased mRNA expression of inhibin beta B (INHBB) and Met by qRT-
PCR. (B) miR-34a decreased protein expression of INHBB and Met by westernblot analysis. Actin was used as sample control. (C) miR-34a-binding site
in the 39-UTR (top) and mutated sites in 39-UTR (bottom) of INHBB constructed in a luciferase system. (D) The 39-UTR of INHBB mediates INHBB
repression. BRL-3A cells were co-transfected with a luciferase reporter vector containing the 39-UTR or mutated sequence of INHBB and miR-34a
mimics (miR-34a) or negative control (NC). pGL3-control vector was used as control. **P,0.01 vs NC.
doi:10.1371/journal.pone.0020238.g003
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Briefly, miRNA was separated from 20–30 mg total RNA using the
Ambion miRNA Isolation Kit (including small RNAs). Fluoresce-
in-labeled miRNAs were used for hybridization on each miRNA
microarray chip containing 1320 probes in triplicate, correspond-
ing to 988 human (including 122 predicted miRNAs), 627mouse,
Figure 4. INHBB downregulation repressed hepatocyte proliferation. (A) Fluorescence (right) and bright light (left) photomicrographs of
FAM-positive cells transfected by FAM-siRNA. Pictures were taken 6 h after transfection. (B) Identification of INHBB knockdown efficiency by siRNA via
qRT-PCR. Actin was used as fold control. (C) INHBB silencing led to growth inhibition in BRL-3A cells by MTT cell proliferation analysis. (siRNA: INHBB
siRNA; Control: control siRNA) *P,0.05 compared to control.
doi:10.1371/journal.pone.0020238.g004
Figure 5. Expression of INHBB and Met in regenerating livers.( A) mRNA expression of INHBB and Met in regenerating liver at 5 d after
resection by qRT-PCR. (B) Protein expression of INHBB and Met in regenerating liver at 5 d by westernblot analysis. Actin was used as sample control.
(C) Expressive patterns of INHBB and INHBA mRNA in the regenerating liver after PHx by qRT-PCR. (D) The activin protein complexes are composed of
inhibin beta A (INHBA) and inhibin beta B (INHBB) subunits.
doi:10.1371/journal.pone.0020238.g005
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microrna.sanger.ac.uk/sequences/). The differential miRNAs
were selected using the program Significance Analysis of
Microarrays (version 2.1). The alterations were defined as those
with either ,0.7- or .1.5-fold changes and the d value ,0.05.
Reverse transcription and quantitative real-time PCR
Total RNA was isolated from prepared liver samples or
transfected cells by Trizol (Invitrogen, Carlsbad) reagent. cDNA
was synthesized following the manufacturer’s protocol (MBI
Fermantas). Quantitative real-time PCR (qRT-PCR) was per-
formed using a standard SYBR green PCR kit (TOYOBO), and
PCR-specific amplification was applied in the Applied Biosystems
(ABI7300) real-timePCRmachine.The relative expressionoftarget
genes (miR-34a, u6, INHBB, Met, INHBA and Actin) was calculated
with the 2
2ggCt method [30]. Primers are listed (Table S3).
Cell culture and transient transfection
An established rat liver cell line BRL-3A was obtained from the
Institute of Biochemistry and Cell Biology, Shanghai, China.
BRL-3A cells were grown in RPMI1640 (GIBCO) with 10% fetal
bovine serum (FBS; GIBCO) in a humidified atmosphere
containing 5% CO2 at 37uC. MiR-34a mimics, negative control
sequences, INHBB siRNA and control siRNA were obtained from
GenePharma, Shanghai, China. All sequences are listed in Table
S1. Transfections were performed using a Lipofectamine
TM 2000
kit (Invitrogen) according to the manufacturer’s instructions. To
monitor the transfection efficiency, Fluorescein (FAM)-siRNA
(GenePharma) was used as control. And successfully transfected
cells were observed under a fluorescence microscope.
Cell proliferation assay by methylthiazoletetrazolium
BRL-3A cells transfected with miR-34a mimics (miR-34a) or
negative control (NC) (GenePharma) and cells transfected with
INHBB siRNA or control siRNA in the 24-well plate were re-
seeded in 96-well plates at an optimized density cells 48 hours (h)
after transfection. At indicated time points, 20 mL methylthiazo-
letetrazolium (MTT) solution (5 mg/mL) was added into the
culture medium for 4 h incubation. Then 150 mL dimethyl
sulfoxide (DMSO) was added to each well to dissolve the crystals.
The absorbance of each sample was recorded at 570 nm after 10
minutes.
Cell cycle analysis by flow cytometry
BRL-3A cells were cultured in 6-well plates and then treated
with miR-34a or NC. 48 h later, cells were collected, fixed by 70%
ethanol for 30 min and then washed with ice-cold PBS. The cell
pellets were re-suspended in RNase-containing (1:100 in dilution)
PBS buffer on ice. At last, the cells were stained with propidium
iodide (PI) and then analyzed using a flow cytometer.
Plasmid construction and Luciferase reporter assay
The 39-UTR of INHBB containing the INHBB-miR-34a
response element was cloned into the XhoI/FseI site of pGL3
control Luciferase vector (Promega). A mutant 39- UTR of INHBB
was synthesized by PCR. Primers are listed in Table S1. BRL-3A
cells were seeded in a 24-well plate (1610
5 per well) and
transfected with INHBB-UTR-pGL3/Mu-INHBB-UTR-pGL3
(200 ng), Renilla luciferase control vector (20 ng) and miR-34a/
NC (15 pmol). 48 h later, all protein extracts were analyzed using
the dual luciferase reporter assay system (Promega).
Westernblot analysis
The levels of INHBB, Met and Actin were determined in whole-
cell extracts from liver tissues (5 d after PHx or SH) or transfected
cells (miR-34a or NC). Protein extracts were separated on a SDS–
polyacrylamide gel, blotted onto a nitrocellulose membrane
(Millipore), and incubated with anti-INHBB (Abcam), anti-Met
(Cell Signaling) or anti-Actin (Cell Signaling). Immunoblots were
developed using goat anti-rabbit or anti-mouse secondary
antibody, followed by detection with enhanced chemilumines-
cence (Pierce).
Statistical analysis
The data shown are represented as means 6 standard
deviation. A P-value of less than 0.05 was considered statistically
significant.
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